Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Laura J. Esserman, MD, of the University of California, San Francisco, explains how to improve breast cancer screening practices.
University of Colorado’s Jennifer Diamond, MD, talks about how clinical trials work in breast cancer and what they can do for patients.
Breast cancer and lymphoma patients who exercised for just 10 minutes had increased numbers of killer T-cells and natural killer cells.
Researchers stress funding breast cancer research to include representation of racially and ethnically diverse populations
Immunotherapy and … nothing else? Studies test a potential paradigm shift in treatment for some people with early stage cancers.
A cancer survivor turned health justice activist who helps other people with cancer navigate the confusing medical system
A look at the symptoms, treatments, risk factors, prognosis and research on breast cancer metastasis to the brain.
A novel clinical trial based on research from Cleveland Clinic’s Lerner Research Institute targets triple-negative breast cancer.
An estrogen receptor known as ERα plays a critical role in more than 70% of breast cancers.
People who received the antibody-drug conjugate were also more likely to experience tumor remission.
Keytruda plus chemotherapy reduced the risk of death by 27% in people with locally advanced or metastatic disease.
The Food and Drug Administration recently approved the checkpoint inhibitor Keytruda (pembrolizumab).
An advisory panel reviewed follow-up data on checkpoint inhibitors, voting to maintain four approvals and rescind two.
Overall survival increased by 30% among women with aggressive breast cancer who began statin use post-diagnosis.
This is the first immunotherapy approved for previously untreated triple-negative breast cancer that is likely to relapse.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.